PamelaACyrusMD

PubMed

• 9 citations
  Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study.
  Ira W. Klimberg, Gerald Shockey, Howard Ellison, Freida Fuller-Jonap, Richard Colgan, James Song, Karen Keating, Pamela Cyrus> ;Current Medical Research and Opinion. 2005 Jul 7
• 18 citations
  Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The...
  John P. Blass, Pamela A. Cyrus, Florian Bieber, Barbara Gulanski> ;Alzheimer Disease and Associated Disorders. 2000 Jan 1
• 71 citations
  The Effects of Metrifonate on the Cognitive, Behavioral, and Functional Performance of Alzheimer's Disease Patients
  Murray A. Raskind, Pamela A. Cyrus, Bianca B. Ruzicka, Barbara Gulanski> ;The Journal of Clinical Psychiatry. 1999 May 1
• 7 citations
  Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: A randomized, double...
  Michael W. Jann, Pamela A. Cyrus, Larry S. Eisner, David L Margolin, Traci Griffin, Barbara Gulanski> ;Clinical Therapeutics. 1999 Jan 1
• 203 citations
  Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease
  John C. Morris, Pamela A. Cyrus, John Orazem, J. Mas, Florian Bieber, Bianca B. Ruzicka, Barbara Gulanski> ;Neurology. 1998 May 1
• 110 citations
  Metrifonate treatment of the cognitive deficits of Alzheimer's disease
  Jeffrey L. Cummings, Pamela A. Cyrus, F. Bieber, J. Mas, J. Orazem, Barbara Gulanski> ;Neurology. 1998 May 1
• 10 citations
  Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose study.
  Neal R. Cutler, Stanford S. Jhee, Pamela A. Cyrus, F. Bieber, Paul TanPiengco, John J. Sramek, Barbara Gulanski> ;Life Sciences. 1998 Mar 13
• Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer''s disease.
  Cummings, J. L., Nadel, A., Masterman, D., Cyrus, P. A.> ;J Geriatr Psychiatry Neurol. 2001
• Metrifonate therapy in Alzheimer''s disease: a pooled analysis of four randomized, double-blind, placebo-controlled trials.
  Farlow, M. R., Cyrus, P. A.> ;Dement Geriatr Cogn Disord. 2000 Jun 27
• Metrifonate enhances the ability of Alzheimer''s disease patients to initiate, organize, and execute instrumental and basic activities of daily living.
  Gélinas, I., Gauthier, S., Cyrus, P. A.> ;J Geriatr Psychiatry Neurol. 2000
• Metrifonate treatment of AD: influence of APOE genotype.
  Farlow, M. R., Cyrus, P. A., Nadel, A., Lahiri, D. K., Brashear, A., Gulanski, B.> ;Neurology. 1999 Dec 10
• Join now to see all